Basic Information
Basic information for SOX2-OT-278-40aa
Peptide Name SOX2-OT-278-40aa
Genome Position chr3:181056723-181056786,181088877-181088917,181175514-181175528[+]
Species Human
Peptide Sequence MERKKYITSSVCPQAFLGAYEVNEGGKKGETEKIWISSWL
Peptide Length 40
Unique No (SOX2-OT-201-40aa,SOX2-OT-215-40aa,SOX2-OT-241-40aa,SOX2-OT-267-40aa,SOX2-OT-277-40aa,SOX2-OT-289-40aa,SOX2-OT-290-40aa,SOX2-OT-300-40aa)
Grand Average of Hydropathicity -0.51
Relative Molecular Mass 5267.87
Experimental Evidences 2:lncORF,ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000645983;SOX2-OT-278
Transcript Length 392
Coding Ability 0.4694
DNA Sequence Corresponding to Peptide ATGGAAAGGAAGAAATATATCACATCATCTGTCTGTCCACAGGCTTTCCTTGGGGCTTATGAAGTGAATGAAGGAGGGAAGAAAGGAGAGACAGAGAAAATATGGATTTCCTCATGGTTG
Experimental Evidences
   lncORF
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :